Access to this symposium requires KEY ZONE access (paid
registration) to HDCN. For information about subscribing to HDCN,
please go to this link. |
|
Inflammation, Dyslipidemia and the Kidney |
| |
|
|
wma |
mp3 |
|
Massy Z. |
Dyslipidemia as a Cause and a Result of CKD |
|
|
|
|
|
Discussion |
|
|
|
|
Tonelli M. |
Inflammation as a Cause and a Result of CKD |
|
|
|
|
|
Discussion |
|
|
|
|
Danovitch G. |
Inflammation, Dyslipidemia and Renal Transplant Recipients |
|
|
|
|
|
Discussion |
|
|
|
|
Kasiske B. |
Debate: Statins Should be Used in All CKD and ESRD Patients
Pro |
|
|
|
|
Landray M. |
Debate: Statins Should be Used in All CKD and ESRD Patients
Con |
|
|
|
|
|
Debate: Discussion |
|
|
|
|
New Insights in IgA Nephropathy |
| |
|
|
wma |
mp3 |
|
Haas M. |
IgA Nephropathy: Pathology and Clinicopathological Correlates |
|
|
|
|
|
Discussion |
|
|
|
|
Monteiro R. |
Properties of IgA1 and its Interaction with IgA Receptors in the Pathogenesis of IgA Nephropathy |
|
|
|
|
|
Discussion |
|
|
|
|
Feehally J. |
Disordered IgA Production in IgA Nephropathy |
|
|
|
|
|
Discussion |
|
|
|
|
Hsu S. |
Mechanism of Progression in IgA Nephropathy |
|
|
|
|
|
Discussion |
|
|
|
Visit us next week for new topics !
|
 |
Audio
tapes from this Symposia can be purchased from:
|
|
